Inhibitor of the transcription factor NF-κB, DHMEQ, enhances the effect of paclitaxel on cells of anaplastic thyroid carcinoma in vitro and in vivo

V.V. Pushkarev; V.M. Pushkarev

doi:10.15407/ubj87.03.063

Inhibitor of the transcription factor NF-κB, DHMEQ, enhances the effect of paclitaxel on cells of anaplastic thyroid carcinoma in vitro and in vivo

V.V. Pushkarev(V.P. Komisarenko Institute of Endocrinology and Metabolism), V.M. Pushkarev(V.P. Komisarenko Institute of Endocrinology and Metabolism)

The Ukrainian Biochemical Journal

June 27, 2015

10.15407/ubj87.03.063

Cited by 9

Related Papers

The Effect of the Combined Action of Roscovitine and Paclitaxel on the Apoptotic and Cell Cycle Regulatory Mechanisms in Colon and Anaplastic Thyroid Cancer Cells

|ISRN Biochemistry|2012|5